sulforaphane has been researched along with Psoriasis in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) has been shown to have anti-inflammatory and antioxidant properties." | 5.91 | Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling. ( Gu, C; Huang, Z; Li, L; Lian, P; Lu, R; Lu, Y; Ma, C; Peng, Z; Pu, W; Ruan, B; Su, Z; Wang, H; Wang, W; Wazir, J; Wei, L; Zong, Y, 2023) |
| "4-Methylthiobutylisothiocyanate (MTBI), the main rocket (Eruca sativa) seed isothiocyanate (ITC), and its oxidized form, sulforaphane (SFN), were assessed for their potential effects on psoriasis-related factors." | 3.78 | Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin. ( Gilhar, A; Milner, Y; Soroka, Y; Tamir, S; Yehuda, H; Zlotkin-Frušić, M, 2012) |
| "Sulforaphane (SFN) has been shown to have anti-inflammatory and antioxidant properties." | 1.91 | Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling. ( Gu, C; Huang, Z; Li, L; Lian, P; Lu, R; Lu, Y; Ma, C; Peng, Z; Pu, W; Ruan, B; Su, Z; Wang, H; Wang, W; Wazir, J; Wei, L; Zong, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, C | 1 |
| Gu, C | 1 |
| Lian, P | 1 |
| Wazir, J | 1 |
| Lu, R | 1 |
| Ruan, B | 1 |
| Wei, L | 1 |
| Li, L | 1 |
| Pu, W | 1 |
| Peng, Z | 1 |
| Wang, W | 1 |
| Zong, Y | 1 |
| Huang, Z | 1 |
| Wang, H | 1 |
| Lu, Y | 1 |
| Su, Z | 1 |
| Yehuda, H | 1 |
| Soroka, Y | 1 |
| Zlotkin-Frušić, M | 1 |
| Gilhar, A | 1 |
| Milner, Y | 1 |
| Tamir, S | 1 |
2 other studies available for sulforaphane and Psoriasis
| Article | Year |
|---|---|
Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling.
Topics: Animals; Antioxidants; Cytokines; Disease Models, Animal; Humans; Inflammation; Kelch-Like ECH-Assoc | 2023 |
Isothiocyanates inhibit psoriasis-related proinflammatory factors in human skin.
Topics: Adolescent; Adult; Animals; Cell Line; Cytokines; Female; Humans; Intercellular Adhesion Molecule-1; | 2012 |